The Role of Liver-Directed Surgery in Patients With Hepatic Metastasis From Primary Breast Cancer: a Multi-Institutional Analysis

Detalhes bibliográficos
Autor(a) principal: Margonis, GA
Data de Publicação: 2016
Outros Autores: Buettner, S, Sasaki, K, Kim, Y, Ratti, F, Russolillo, N, Ferrero, A, Berger, N, Gamblin, TC, Poultsides, G, Tran, T, Postlewait, LM, Maithel, S, Michaels, AD, Bauer, TW, Pinto Marques, H, Barroso, E, Aldrighetti, L, Pawlik, TM
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: http://hdl.handle.net/10400.17/3004
Resumo: BACKGROUND: Data on surgical management of breast liver metastasis are limited. We sought to determine the safety and long-term outcome of patients undergoing hepatic resection of breast cancer liver metastases (BCLM). METHODS: Using a multi-institutional, international database, 131 patients who underwent surgery for BCLM between 1980 and 2014 were identified. Clinicopathologic and outcome data were collected and analyzed. RESULTS: Median tumor size of the primary breast cancer was 2.5 cm (IQR: 2.0-3.2); 58 (59.8%) patients had primary tumor nodal metastasis. The median time from diagnosis of breast cancer to metastasectomy was 34 months (IQR: 16.8-61.3). The mean size of the largest liver lesion was 3.0 cm (2.0-5.0); half of patients (52.0%) had a solitary metastasis. An R0 resection was achieved in most cases (90.8%). Postoperative morbidity and mortality were 22.8% and 0%, respectively. Median and 3-year overall-survival was 53.4 months and 75.2%, respectively. On multivariable analysis, positive surgical margin (HR 3.57, 95% CI 1.40-9.16; p = 0.008) and diameter of the BCLM (HR 1.03, 95% CI 1.01-1.06; p = 0.002) remained associated with worse OS. DISCUSSION: In selected patients, resection of breast cancer liver metastases can be done safely and a subset of patients may derive a relatively long survival, especially from a margin negative resection.
id RCAP_db33407afe741c0e186b6477c7bdef5e
oai_identifier_str oai:repositorio.chlc.min-saude.pt:10400.17/3004
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling The Role of Liver-Directed Surgery in Patients With Hepatic Metastasis From Primary Breast Cancer: a Multi-Institutional AnalysisAgedBreast NeoplasmsDatabases, FactualFemaleHumansItalyKaplan-Meier EstimateLiver NeoplasmsMargins of ExcisionMetastasectomyMiddle AgedMultivariate AnalysisPortugalProportional Hazards ModelsRisk FactorsTime FactorsTreatment OutcomeTumor BurdenUnited StatesHepatectomyCHLC CHBPTBACKGROUND: Data on surgical management of breast liver metastasis are limited. We sought to determine the safety and long-term outcome of patients undergoing hepatic resection of breast cancer liver metastases (BCLM). METHODS: Using a multi-institutional, international database, 131 patients who underwent surgery for BCLM between 1980 and 2014 were identified. Clinicopathologic and outcome data were collected and analyzed. RESULTS: Median tumor size of the primary breast cancer was 2.5 cm (IQR: 2.0-3.2); 58 (59.8%) patients had primary tumor nodal metastasis. The median time from diagnosis of breast cancer to metastasectomy was 34 months (IQR: 16.8-61.3). The mean size of the largest liver lesion was 3.0 cm (2.0-5.0); half of patients (52.0%) had a solitary metastasis. An R0 resection was achieved in most cases (90.8%). Postoperative morbidity and mortality were 22.8% and 0%, respectively. Median and 3-year overall-survival was 53.4 months and 75.2%, respectively. On multivariable analysis, positive surgical margin (HR 3.57, 95% CI 1.40-9.16; p = 0.008) and diameter of the BCLM (HR 1.03, 95% CI 1.01-1.06; p = 0.002) remained associated with worse OS. DISCUSSION: In selected patients, resection of breast cancer liver metastases can be done safely and a subset of patients may derive a relatively long survival, especially from a margin negative resection.ElsevierRepositório do Centro Hospitalar Universitário de Lisboa Central, EPEMargonis, GABuettner, SSasaki, KKim, YRatti, FRussolillo, NFerrero, ABerger, NGamblin, TCPoultsides, GTran, TPostlewait, LMMaithel, SMichaels, ADBauer, TWPinto Marques, HBarroso, EAldrighetti, LPawlik, TM2018-07-12T15:13:17Z20162016-01-01T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttp://hdl.handle.net/10400.17/3004engHPB (Oxford). 2016 Aug;18(8):700-5.10.1016/j.hpb.2016.05.014info:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2023-03-10T09:40:45Zoai:repositorio.chlc.min-saude.pt:10400.17/3004Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T17:20:18.987107Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv The Role of Liver-Directed Surgery in Patients With Hepatic Metastasis From Primary Breast Cancer: a Multi-Institutional Analysis
title The Role of Liver-Directed Surgery in Patients With Hepatic Metastasis From Primary Breast Cancer: a Multi-Institutional Analysis
spellingShingle The Role of Liver-Directed Surgery in Patients With Hepatic Metastasis From Primary Breast Cancer: a Multi-Institutional Analysis
Margonis, GA
Aged
Breast Neoplasms
Databases, Factual
Female
Humans
Italy
Kaplan-Meier Estimate
Liver Neoplasms
Margins of Excision
Metastasectomy
Middle Aged
Multivariate Analysis
Portugal
Proportional Hazards Models
Risk Factors
Time Factors
Treatment Outcome
Tumor Burden
United States
Hepatectomy
CHLC CHBPT
title_short The Role of Liver-Directed Surgery in Patients With Hepatic Metastasis From Primary Breast Cancer: a Multi-Institutional Analysis
title_full The Role of Liver-Directed Surgery in Patients With Hepatic Metastasis From Primary Breast Cancer: a Multi-Institutional Analysis
title_fullStr The Role of Liver-Directed Surgery in Patients With Hepatic Metastasis From Primary Breast Cancer: a Multi-Institutional Analysis
title_full_unstemmed The Role of Liver-Directed Surgery in Patients With Hepatic Metastasis From Primary Breast Cancer: a Multi-Institutional Analysis
title_sort The Role of Liver-Directed Surgery in Patients With Hepatic Metastasis From Primary Breast Cancer: a Multi-Institutional Analysis
author Margonis, GA
author_facet Margonis, GA
Buettner, S
Sasaki, K
Kim, Y
Ratti, F
Russolillo, N
Ferrero, A
Berger, N
Gamblin, TC
Poultsides, G
Tran, T
Postlewait, LM
Maithel, S
Michaels, AD
Bauer, TW
Pinto Marques, H
Barroso, E
Aldrighetti, L
Pawlik, TM
author_role author
author2 Buettner, S
Sasaki, K
Kim, Y
Ratti, F
Russolillo, N
Ferrero, A
Berger, N
Gamblin, TC
Poultsides, G
Tran, T
Postlewait, LM
Maithel, S
Michaels, AD
Bauer, TW
Pinto Marques, H
Barroso, E
Aldrighetti, L
Pawlik, TM
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
dc.contributor.none.fl_str_mv Repositório do Centro Hospitalar Universitário de Lisboa Central, EPE
dc.contributor.author.fl_str_mv Margonis, GA
Buettner, S
Sasaki, K
Kim, Y
Ratti, F
Russolillo, N
Ferrero, A
Berger, N
Gamblin, TC
Poultsides, G
Tran, T
Postlewait, LM
Maithel, S
Michaels, AD
Bauer, TW
Pinto Marques, H
Barroso, E
Aldrighetti, L
Pawlik, TM
dc.subject.por.fl_str_mv Aged
Breast Neoplasms
Databases, Factual
Female
Humans
Italy
Kaplan-Meier Estimate
Liver Neoplasms
Margins of Excision
Metastasectomy
Middle Aged
Multivariate Analysis
Portugal
Proportional Hazards Models
Risk Factors
Time Factors
Treatment Outcome
Tumor Burden
United States
Hepatectomy
CHLC CHBPT
topic Aged
Breast Neoplasms
Databases, Factual
Female
Humans
Italy
Kaplan-Meier Estimate
Liver Neoplasms
Margins of Excision
Metastasectomy
Middle Aged
Multivariate Analysis
Portugal
Proportional Hazards Models
Risk Factors
Time Factors
Treatment Outcome
Tumor Burden
United States
Hepatectomy
CHLC CHBPT
description BACKGROUND: Data on surgical management of breast liver metastasis are limited. We sought to determine the safety and long-term outcome of patients undergoing hepatic resection of breast cancer liver metastases (BCLM). METHODS: Using a multi-institutional, international database, 131 patients who underwent surgery for BCLM between 1980 and 2014 were identified. Clinicopathologic and outcome data were collected and analyzed. RESULTS: Median tumor size of the primary breast cancer was 2.5 cm (IQR: 2.0-3.2); 58 (59.8%) patients had primary tumor nodal metastasis. The median time from diagnosis of breast cancer to metastasectomy was 34 months (IQR: 16.8-61.3). The mean size of the largest liver lesion was 3.0 cm (2.0-5.0); half of patients (52.0%) had a solitary metastasis. An R0 resection was achieved in most cases (90.8%). Postoperative morbidity and mortality were 22.8% and 0%, respectively. Median and 3-year overall-survival was 53.4 months and 75.2%, respectively. On multivariable analysis, positive surgical margin (HR 3.57, 95% CI 1.40-9.16; p = 0.008) and diameter of the BCLM (HR 1.03, 95% CI 1.01-1.06; p = 0.002) remained associated with worse OS. DISCUSSION: In selected patients, resection of breast cancer liver metastases can be done safely and a subset of patients may derive a relatively long survival, especially from a margin negative resection.
publishDate 2016
dc.date.none.fl_str_mv 2016
2016-01-01T00:00:00Z
2018-07-12T15:13:17Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10400.17/3004
url http://hdl.handle.net/10400.17/3004
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv HPB (Oxford). 2016 Aug;18(8):700-5.
10.1016/j.hpb.2016.05.014
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Elsevier
publisher.none.fl_str_mv Elsevier
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1817552422017433600